Skip to main content
World Journal of Gastroenterology logoLink to World Journal of Gastroenterology
. 2005 Mar 14;11(10):1473–1480. doi: 10.3748/wjg.v11.i10.1473

Vegetable/fruit, smoking, glutathione S-transferase polymorphisms and risk for colorectal cancer in Taiwan

Chih-Ching Yeh 1,2,3,4, Ling-Ling Hsieh 1,2,3,4, Reiping Tang 1,2,3,4, Chung Rong Chang-Chieh 1,2,3,4, Fung-Chang Sung 1,2,3,4
PMCID: PMC4305689  PMID: 15770723

Abstract

AIM: To investigate the colorectal cancer risk associated with polymorphic GSTM1, GSTT1 and GSTP1 and the effect of diet and smoking.

METHODS: With consents, genotypes of the genes were determined using PCR methods for 727 cases and 736 sex and age-matched healthy controls recruited at a medical center in the Northern Taiwan. Nurses who were blind to the study hypothesis conducted interviews with study participants for the information of socio-demographic variables, diet and smoking.

RESULTS: There was no significant association between GSTM1 genotypes and the disease. Men, not women, with GSTT1 null genotype were at significant risk of colorectal cancer, but limited to rectal tumor, and in men aged 60 years and less. The corresponding association with the GSTP1 with G allele compared to GSTP1 A/A genotype was at borderline significance. Compared to men with GSTT1 present and GSTP1 A/A combined, men with both GSTT1 null and GSTP1 with G allele genotypes were at significant risk (odds ratio (OR) = 1.91, 95% confidence interval (CI) = 1.21-3.02), also limited to the rectal tumor and younger men. The beneficial effects of vegetable/fruit intake on colorectal cancer were much higher for men with GSTT1 present (OR = 0.32, 95%CI = 0.20-0.50) or GSTP1 A/A genotypes (OR = 0.40, 95%CI = 0.25-0.64). These effects remained significant for women. But, the greatest protective effect from vegetable/fruit intake for women was observed in those with GSTT1 null or GSTP1 with G allele genotypes. In addition, non-smoking men benefitted significantly from combined effect of higher vegetable/fruit intake and GSTT1 present or GSTP1 A/A genotypes with OR = 0.17 and 0.21 respectively.

CONCLUSION: This study suggests that the GSTT1 gene can modulate the colorectal cancer risk and vegetable/fruit-related colorectal cancer risk, particularly in men of no smoking history.

Keywords: Colorectal cancer, Glutathione S-transferase, Polymorphisms, Vegetables, Smoking

INTRODUCTION

Human glutathione S-transferase (GST) consists of four main classes, alpha (A), mu (M), pi (P) and theta (T)[1], involving in the detoxification of many electrophilic compounds by conjugation reaction with glutathione[2]. Most GST substrates are thought as xenobiotics or products of oxidative stress, including polycyclic aromatic hydrocarbons present in the diet or from tobacco smoke[2]. The GST enzymes also conjugate isothiocyanates, potent enzyme inducers, detoxifying mutagens[3] to glutathione and divert them from the enzyme induction pathway to excretion[4,5]. Functional polymorphisms known in most studies are GSTM1, GSTT1 and GSTP1[6-8]. The absence of GSTM1 and GSTT1 enzyme activity correlates with homozygosity for deletions in these genes, termed the null genotype[6,7]. For GSTP1, a polymorphic Ile105Val (resulting from an A to G substitution at base 1 578) has been found to modify the enzyme’s activity and affinity for electrophilic substrates[8]. Studies have shown that higher levels of DNA damage are associated with the GSTM1/T1 null genotype and GSTP1 with G allele[9,10].

Several studies have examined the relationship between the GSTM1 null genotype and susceptibility to colorectal cancer[11-15]. The first study by Zhong et al[16] found significantly increased colon cancer risk associated with the GSTM1 null genotype, particular for cancers of the proximal colon. A significant risk for distal colorectal cancer was observed later in a Japanese study[17]. Sgambato et al[15] also reported strongest association between GSTM1 null genotype and colon cancer and with a younger age (<60 years) of onset. Other studies failed to find similar associations[11-14]. Several studies also examined whether the GSTT1 null genotype exhibition conferred susceptibility to colorectal cancer[11-15]. Only the largest study[18], with 252 cases and 577 controls, demonstrated an increased risk for the GSTT1 null genotype due to excess GSTT1 deletion for cases with left colon and rectal cancer. Five studies examined the GSTP1 A/G polymorphism for colorectal cancer. None reported a significant association[11,12,19-21].

Differences in carcinogen metabolism might explain the differences in cancer susceptibility especially as most cancers are influenced by environmental factors[22]. Etiological studies have attributed more than 85% of colorectal cancer to environmental factors[23,24], particularly dietary factors[25]. These dietary effects might be modulated by genetic polymorphisms of the metabolic genes[26]. For instance, Lin et al[27] found that the protective effect of broccoli for colorectal adenoma was observed only among subjects with the GSTM1 null genotype. Recent GST polymorphism studies have focused on gene-environment interactions in the occurrence of colorectal cancer[14,28-30]. Slattery et al[30] reported that the beneficial effect of cruciferous vegetable intake was stronger for subjects aged less than 55 years old, with GSTM1 null genotype than with GSTM1 present genotype.

Three studies linking these GST polymorphisms with colorectal cancer for Chinese subjects[31-33] were limited to small sample sizes or no control for potential confounders. In addition, the incidence of colorectal cancer increased 2.6 folds in the past decade in Taiwan and dietary behavior has changed by increasing meat consumption. The present hospital-based case-control study examined the role of polymorphisms of GSTM1, GSTT1 and GSTP1 genes in colorectal cancer and their combined effects with environmental factors such as meat consumption, cigarette smoking and vegetable/fruit intake.

MATERIALS AND METHODS

Subjects

Detailed descriptions for the study participants have been published previously[34]. In brief, the colorectal adenocarcinoma cancer cases (n = 776) were newly diagnosed and histologically confirmed at the Chang Gung Memorial Hospital between January 1995 and January 1999. Patients with familial adenomatous polyposis (n = 11), hereditary nonpolyposis colorectal cancer (n = 18), or inflammatory bowel disease and other malignancies (n = 20) were excluded from the data analysis. Seven hundred and twenty-seven cases (94%) were included (56.4% men) in this study. During the same period, seven hundred and forty-seven subjects were recruited as controls from the Physical Check-Up Department for comprehensive health examinations including colonoscopies matched by same age and sex. After excluding individuals diagnosed with other colorectal diseases (n = 5) and with a history of other cancers (n = 6), 736 controls (98%) were included (55.6% men) in this study.

Questionnaire

Professional nurses employed were trained to conduct interviews with all participants in the hospital prior to surgical operations for cases and colonoscopies for the controls. These nurses were blind to the study hypothesis regarding diet, lifestyle and colorectal cancer. All interviews were administered uniformly in the wards. The standardized interview was conducted with informed consent using a structured questionnaire covering socio-demographic characteristics, lifestyle factors (including physical activities, cigarette and alcohol use and coffee intake), dietary consumption and medical history. The reliability (standardized Cronbach’s alpha) of this questionnaire was 0.92 based on the lifestyle and dietary variables. This interview took approximately 20 min to complete. Information on usual dietary intake 5 years preceding the date of diagnosis for the cases and the date of selection for the controls was collected. The intake frequency was categorized into six levels ranging from never, less than once a month, 1-3 times a month, once a week, 2-3 times a week to almost everyday.

Cigarette and alcohol use and coffee intake were evaluated in both the amount and duration. Total cigarette smoking and alcohol drinking were estimated in pack-years and bottle-years using daily pack and bottle (600 mL) consumption multiplied by the number of years respectively. Because less than 10% of the subjects in our study had a coffee intake habit (more than one cup of coffee per month), coffee intake was estimated by status (“Yes” or “No”) rather than total consumption.

Genotyping

WBC DNA was isolated from 10 mL whole blood using standard procedures with sodium dodecyl sulfate (SDS)-proteinase K-RNase digestion and phenol-chloroform extraction. The extracted DNA was dissolved in Tris-EDTA buffer to a concentration of 500 ng/μL. The polymorphisms were analyzed by polymerase chain reaction (PCR) assays for GSTM1 and GSTT1 or combined with restriction fragment length polymorphism (RFLP) assays for GSTP1 Ile105Val. All of the PCR reactions were performed in a 25 μL final volume containing 200 ng of each primer, 100 ng genomic DNA, 1.5 mmol/L MgCl2, 200 μmol/L dNTPs and 1.0 unit of Taq DNA Polymerase in the buffer provided by the manufacturer. Amplification was performed in a Programmable Thermal Controller (MJ Research, Waltham, MA) for the PCR reaction.

The multiple PCR used to detect the presence or absence of the GSTM1 and GSTT1 genes was determined using the following primers: GSTT1 (5’-TTCCTTACTGGTCC-TCACATCTC-3’ and 5’-CACCGGATCATGGCCAGCA-3’), GSTM1 (5’-TGCCCTACTTGATTGATGGG-3’ and 5’-CTGGATTGTAGCAGATCATGC-3’) and the internal control, β-globin (5’-CACAACTGTGTTCACTAGC-3’ and 5’-CAACTTCATCCACGTTCACC-3’). The PCR program was a 5-min denaturing step at 94 °C followed by 30 cycles of 30 s at 94 °C, 30 s at 59 °C and 60 s at 72 °C. Individuals without intact GSTT1 or GSTM1 genes showed no amplification of the 480 bp GSTT1 fragment or the 273 bp GSTM1 fragment and a positive internal control[35]. The GSTP1 A/G (Ile105Val) polymorphism was determined using the following primers: sense, 5’-CCTCTCCCTTTCCT-CTGTTC-3’; antisense, 5’-CAGGTGAGGGGGACATCT-3’. PCR program was a 5-min denaturing step at 95 °C followed by 30 cycles of 30 s at 94 °C, 30 s at 55 °C and 30 s at 72 °C. The 176 bp PCR product was digested with Alw26I (New England BioLabs, Beverly, MA): the Val allele was cut into 91 and 85 bp fragments (Ile allele not digested)[36].

Statistical analysis

Food items were coded into three major groups: staples (rice, noodles and instant noodles), meat (red meat and white meat), and vegetables and fruits. Viscera fish and shrimp were considered separate food items in the data analysis. The consumption of each food item was scored from 1 for “almost ate every day” to 6 for “never ate”. The group score was the total sum of scores from the intake frequency for the individual food items. Because of etiological differences between colon cancer and rectal cancer and between men and women[37], all analyses in this study were estimated separately by sex and cancer site. Most risk factors were dichotomized into “Low” and “High” according to the median of the controls in the data analysis. Only 4% of the women were smokers and only 5.1% of women were alcohol users. The risks for these two factors were therefore calculated only for men.

Some unmatched cases occurred when we were unable to interview an eligible control or controls who were eliminated by the exclusion criteria. Unmatched controls also occurred when cases with hereditary syndromes or other malignancies were excluded. To make the use of information on unmatched subjects, and because we had to break the matches due to stratification by sex and tumor site, unconditional logistic regression was used to control for the matching factor (age as continuous variable) to identify potential risk factors. The odds ratio (OR) and the 95% confidence interval (CI) were measured. A stepwise selection procedure was applied to determine the covariates included in the final multivariate models beginning with all dietary and non-dietary variables. Multivariate unconditional logistic regressions were also used to examine the association between the GSTM1, GSTT1 and GSTP1 polymorphisms and risk for colorectal cancer controlling for age and selected covariates. We conducted interaction analyses on the basis of a multiplicative scale. The likelihood ratio test was used to evaluate the interaction between GST genes and cigarette smoking, meat consumption and vegetable/fruit intake on the risk for colorectal cancer. Analysis was also conducted separately to observe the differences between age groups at diagnosis. All analyses were performed using the SAS statistical package (version 8.2 for Windows; SAS Institute, Inc., Cary, NC) and all statistical tests were two-sided.

RESULTS

Overall, 410 men and 317 women with eligible colorectal cancer cases and 409 male and 327 female controls were included in this analysis. These four groups of subjects had a similar average age of 60 years (Table 1). The stepwise selection procedure produced six potential covariates, including age, physical activity, coffee use, cigarette smoking, drinking, and meat consumption associated with the disease for men. The three potential risk covariates for women included age, consumption of staples and meat. Vegetable/fruit and fish/shrimp intakes had protective effect for both men and women. The frequencies of the polymorphisms for GSTM1, GSTT1 and GSTP1 genes were also presented in Table 1. Only the GSTT1 null genotype was moderately higher in cases than in controls (0.55 vs 0.49, P = 0.06). Because of the low frequency of the GSTP1 G/G genotype, we combined heterozygous (GSTP1 A/G) and homozygous (GSTP1 G/G) genotypes, as GSTP1 with G allele, to estimate the cancer risk associated with the G allele.

Table 1.

Selected colorectal cancer case and control distribution by sex in Taiwan.

Variable Men
P1 Women
P1
Casesn = 410 (%) Controlsn = 409 (%) Cases n = 317 (%) Controlsn = 327 (%)
Age (mean±SD, yr) 60.5±12.2 60.6±12.7 60.2±13.6 60.7±13.4
Colon/rectum, n 185/225 167/150
Physical activity 53 (14.1) 95 (23.2) <0.01 NI2
Coffee 63 (16.5) 36 ( 8.8) <0.01 NI2
Smoking 0.18 NA3
Never 122 (31.3) 150 (36.7)
Ex-smoker 91 (23.3) 98 (24.0)
Current 177 (45.4) 161 (39.4)
Alcohol drinking 0.01 NA3
Never 186 (48.1) 205 (50.1)
Ex-drinker 17 (4.4) 37 (9.1)
Current 184 (47.6) 167 (40.8)
High staple4 NI2 156(49.2) 112 (34.3) <0.01
High meat4 294 (71.7) 244 (59.7) <0.01 203 (64.0) 151 (46.2) <0.01
High vegetable/fruit4 168 (44.7) 266 (65.0) <0.01 147 (50.2) 197 (60.2) 0.01
Fish/shrimp (almost everyday) 174 (46.3) 256 (62.6) <0.01 125 (42.8) 167 (51.1) 0.04
GSTM1 null 213 (52.2) 215 (52.7) 0.89 189 (60.0) 195 (60.0) 1.00
GSTT1 null 216 (52.9) 189 (46.3) 0.06 180 (57.1) 171 (52.6) 0.25
GSTP1 0.78 0.39
A/A 277 (67.9) 287 (70.2) 224 (71.3) 226 (69.5)
A/G 117 (28.7) 109 (26.7) 84 (26.8) 87 (26.8)
G/G 14 (3.4) 13 (3.2) 6(1.9) 12 (3.7)

1χ2; 2Not included as covariates in the multiple logistic regression model; 3Not available for analysis; 4The cut-point of score using the median of the score distribution among controls for high consumption of staple, meat and vegetable/fruit were <10, <5 and <3 respectively.

The ORs of the polymorphisms of GSTM1, GSTT1 and GSTP1 for the colorectal cancer risks in men were shown in Table 2. After controlling for covariates, the risk for colorectal cancer was statistically significantly increased by GSTT1 null genotype (OR = 1.45, 95%CI = 1.07-1.97), compared to GSTT1 present genotype. A moderately increased risk for colorectal cancer was also observed in men with GSTP1 with G allele than those with A/A genotype (OR = 1.36, 95%CI = 0.98-1.89). Further stratified analysis by tumor site and age at diagnosis showed that, male individuals with the GSTT1 null genotype were at significant risk for rectal cancer with OR = 1.55 (95%CI = 1.08-2.23) and those diagnosed before 60 years old with OR = 2.03 (95%CI = 1.29-3.21) respectively. An increased risk for GSTP1 with G allele was also observed in these subgroups. However, the polymorphism of GSTM1 gene was not associated with colorectal cancer even in the stratified analysis.

Table 2.

Odds ratio (OR) and 95% confidence interval (CI) of the polymorphisms of GSTM1, GSTT1 and GSTP1 for colorectal cancer by age at diagnosis and tumor site in men.

GSTP1
GSTP1
GSTP1
Present Null Present Null A/A With G2
Total population
Cases/Controls 195/193 213/215 192/219 216/189 277/287 131/122
OR (95%CI)1 1.0 0.93 (0.68-1.26) 1.0 1.45 (1.07-1.97) 1.0 1.36 (0.98-1.89)
Tumor site
Colon
Cases/Controls 82/193 101/215 89/219 94/189 127/287 56/122
OR (95%CI)1 1.0 1.00 (0.67-1.48) 1.0 1.24 (0.83-1.83) 1.0 1.15 (0.75-1.76)
Rectum
Cases/Controls 113/193 112/215 103/219 122/189 150/287 75/122
OR (95%CI)1 1.0 0.87 (0.61-1.25) 1.0 1.55 (1.08-2.23) 1.0 1.48 (1.00-2.18)
Age at diagnosis
≤60 yr
Cases/Controls 95/85 92/100 86/106 101/79 124/129 63/56
OR (95%CI)1 1.0 0.86 (0.53-1.30) 1.0 2.03 (1.29-3.21) 1.0 1.45 (0.89-2.37)
>60 yr
Cases/Controls 100/108 121/115 106/113 115/110 153/158 68/66
OR (95%CI)1 1.0 1.03 (0.67-1.58) 1.0 1.12 (0.73-1.71) 1.0 1.34 (0.84-2.12)
1

ORs and 95%CIs were estimated from multivariate unconditional logistic regressions controlling for age, physical activity, coffee, cigarette, alcohol, meat, vegetable/fruit and fish/shrimp;

2

Combined genotype of A/G and G/G.

The associations between these polymorphisms of GST and the colorectal cancer risks in women were shown in Table 3. No significant difference in proportions of GSTM1 null, GSTT1 null and GSTP1 with G allele genotypes were observed between cases and controls for all female subjects and their subgroups by anatomical site and diagnosed age.

Table 3.

Odds ratio (OR) and 95% confidence interval (CI) of the polymorphisms of GSTM1, GSTT1 and GSTP1 for colorectal cancer by age at diagnosis and tumor site in women.

GSTM1
GSTT1
GSTP1
Present Null Present Null A/A WithG2
Total population
Cases/Controls 126/130 189/195 135/154 180/171 224/226 90/99
OR (95%CI)1 1.0 0.99 (0.71-1.38) 1.0 1.18 (0.85-1.64) 1.0 1.00 (0.70-1.43)
Tumor site
Colon
Cases/Controls 61/130 105/195 72/154 94/171 116/226 49/99
OR (95%CI)1 1.0 1.19 (0.78-1.81) 1.0 1.23 (0.82-1.84) 1.0 1.04 (0.67-1.60)
Rectum
Cases/Controls 65/130 84/195 63/154 86/171 108/226 41/99
OR (95%CI)1 1.0 0.84 (0.56-1.27) 1.0 1.20 (0.79-1.81) 1.0 0.93 (0.60-1.46)
Age at diagnosis
≤60 yr
Cases/Controls 52/52 84/82 50/55 86/79 99/89 37/45
OR (95%CI)1 1.0 1.08 (0.63-1.85) 1.0 1.20 (0.71-2.05) 1 0.84 (0.48-1.47)
>60 yr
Cases/Controls 74/78 105/113 85/99 94/92 125/137 53/54
OR (95%CI)1 1.0 0.95 (0.61-1.46) 1.0 1.15 (0.75-1.76) 1.0 1.13 (0.71-1.80)
1

ORs and 95%CIs were estimated from multivariate unconditional logistic regressions controlling for age, sex, physical activity, coffee, cigarette, alcohol, meat, vegetable/fruit and fish/shrimp;

2

Combined genotype of A/G and G/G.

Men with more risk genotypes of GSTT1 and GSTP1 had higher risk than those without any risk genotypes (trend test P<0.01) (Table 4). Compared to men with both GSTT1 present and GSTP1 A/A genotypes, those with either or both GSTT1 null and GSTP1 with G allele genotypes had 1.4-fold (OR = 1.42, 95%CI = 1.01-1.99) and 1.9-fold (OR = 1.91, 95%CI = 1.21-3.02) risk of colorectal cancer respectively. A stronger risk of rectal cancer was seen for men with both GSTT1 null and GSTP1 with G allele genotypes (OR = 2.20, 95%CI = 1.28-3.78). The corresponding effect on colorectal cancer for men aged less than 60 years at diagnoses was even greater (OR = 3.05, 95%CI = 1.51-6.12). However, these trends were not observed for women (data not shown).

Table 4.

Combined genotype of GSTT1 and GSTP1 on colorectal cancer risk by tumor site and age in men.

GSTT1 / GSTP1
Present / (A/A)
Present /with G + null / (A/A)
Null /with G
Cases/Controls OR (95%CI)1 Cases/Controls OR (95%CI)1 Cases/Controls OR (95%CI)1
Total population2 132/157 1.00 205/191 1.42 (1.01-1.99) 71/60 1.91 (1.21-3.02)
Tumor site
Colon 64/157 1 88/191 1.16 (0.75-1.79) 31/60 1.42 (0.79-2.55)
Rectum2 68/157 1.00 117/191 1.65 (1.09-2.50) 40/60 2.20 (1.28-3.78)
Age at diagnosis
≤60 yr2 57/73 1.00 96/89 1.73 (1.04-2.89) 34/23 3.05 (1.51-6.12)
>60 yr 75/84 1.00 109/102 1.25 (0.78-2.02) 37/37 1.41 (0.75-2.64)
1

Adjusted for age, physical activity, coffee, cigarette, alcohol, meat, vegetable/fruit and fish/shrimp;

2

Trend test P<0.01.

Table 5 demonstrated a multiplicative synergistic effect for men and an antagonistic effect for women between the GST genes (GSTT1 and GSTP1) and vegetable/fruit intake on the colorectal cancer risk. The protective effect of high vegetable/fruit consumption was enhanced for men with GSTT1 present genotype (OR = 0.32, 95%CI = 0.21-0.50), compared to men with GSTT1 null genotype and low vegetable/fruit consumption. Similarly, the protective effect for men was strongly associated with GSTP1 A/A genotype and high vegetable/fruit consumption (OR = 0.40, 95%CI = 0.25-0.64). However, the beneficial effect of high vegetable/fruit intake was attenuated for women with the protective GSTT1 present or GSTP1 A/A genotypes. The strongest protective effect from vegetable/fruit intake was observed among women having GSTT1 null or GSTP1 with G allele genotypes. The stratification analysis also showed that the multiplicative protective effect was also significant in the rectum and for younger men (data not shown).

Table 5.

Combined effects of GST genotypes and vegetable/fruit consumption on colorectal cancer risk.

Genotype Vegetable/fruit consumption Men
Women
Cases Controls OR (95%CI)1 Cases Controls OR (95%CI)2
GSTT1
Null Low 106 69 1.00 90 62 1
Present Low 101 74 0.87 (0.55-1.36) 54 66 0.60 (0.36-0.98)
Null High 110 120 0.57 (0.37-0.88) 90 109 0.47 (0.30-0.75)
Present High 91 145 0.32 (0.20-0.50) 81 88 0.53 (0.33-0.85)
P for interaction 0.21 0.06
GSTP1
With G Low 60 49 1.00 44 35 1
A/A Low 147 94 1.09 (0.67-1.76) 99 93 0.84 (0.49-1.45)
With G High 71 73 0.73 (0.43-1.25) 46 64 0.51 (0.28-0.94)
A/A High 130 193 0.40 (0.25-0.64) 125 133 0.58 (0.34-0.99)
P for interaction 0.03 0.42
1

Adjusted for age, physical activity, coffee, cigarette, alcohol, meat, vegetable/fruit and fish/shrimp;

2

Adjusted for age, staple, meat, vegetable/fruit and fish/shrimp.

The combined effects of GSTT1 present or GSTP1 A/A genotypes, and vegetable/fruit intake on colorectal cancer varied with smoking status (Table 6). Since very few women were smokers (<5%); this stratification analysis by smoking status was calculated only for men. The protective effects of high vegetable/fruit consumption enhanced by the GSTT1 present or GSTP1 A/A genotypes were consistent and the association was robust, particularly for non-smokers. The ORs for these joint effects were 0.17 (95% CI = 0.07-0.42) for GSTT1 and 0.21 (95% CI = 0.09-0.52) for GSTP1. There was no significant interaction between meat intake and GST genes to the risk of colorectal cancer (data not shown).

Table 6.

Smoking specific risk for colorectal cancer for the combined effects of GST genotypes and vegetable/fruit consumption in men.

Genotype Vegetable/fruit consumption Non-smokers
Smokers
Cases Controls OR (95% CI)1 Cases Controls OR (95% CI)1
GSTT1
Present Low 28 16 0.85 (0.33-2.21) 73 58 0.85 (0.51-1.41)
Null High 45 55 0.41 (0.18-0.96) 59 65 0.66 (0.39-1.11)
Present High 25 65 0.17 (0.07-0.42) 52 80 0.43 (0.25-0.73)
P for interaction 0.23 0.49
GSTP1
With G Low 19 10 1.00 41 39 1
A/A Low 32 19 0.80 (0.30-2.15) 115 75 1.21 (0.69-2.12)
With G High 25 33 0.41 (0.15-1.10) 40 40 0.96 (0.49-1.88)
A/A High 45 88 0.21 (0.09-0.52) 71 105 0.55 (0.31-0.98)
P for interaction 0.48 0.07
1

Adjusted for age, physical activity, coffee, alcohol, meat and fish/shrimp.

DISCUSSION

This is the first hospital-based case-control study with a relatively large sample simultaneously examining the association between GSTM1, GSTT1 and GSTP1 polymorphisms and colorectal cancer risk for a Chinese population in Taiwan. The results revealed an elevated risk for colorectal cancer for men with GSTT1 null and GSTP1 with G allele genotypes, particularly for rectal cancer and diagnosed before 60 years old. We also found a very significant protective effect for men with GSTT1 present or GSTP1 A/A genotypes and higher consumption of vegetable/fruit. This combined effect reduces the risk for colorectal cancer to 0.40 or less, even for smokers, and further to about 0.20 for non-smokers, suggesting that these metabolic genes can modulate the risk of vegetable/fruit related colorectal cancer.

There is conflicting evidence concerning the role of GST polymorphisms in colorectal cancer susceptibility. It might be associated with the ethnic differences in allele frequency for these polymorphisms[11]. Carcinogen exposures might vary among populations with the pathogenesis for colorectal cancer differing by tumor site. Moreover, inadequate study design such as non-random sampling, limited sample size and little attempt to adjust for potential confounders should also be considered.

It seems unlikely that the GSTM1 null genotype could predispose an individual to colorectal cancer because GSTM1 is only expressed at low levels in the colon[38]. Conversely, GSTT1 and GSTP1 seem more likely susceptibility gene candidates because they are the predominant GST isoenzymes in colorectal tissue[38,39] and are involved in the inactivation of heterocyclic amine[40]. One previous publication on the GSTP1 A/G (Ile105Val) polymorphism identified that subjects having GSTP1 with G allele are at an elevated risk compared to those with the A/A genotype (OR = 1.77, 95%CI = 1.03-3.06)[36]. However, one of the Alpha class isoenzymes, GSTA1, abundant in the human liver not colon, can also catalyze the detoxification of N-acetoxy-PhIP[40,41] and increases the risk of colorectal cancer[41]. Association between the polymorphism of GSTA1 and the risk of colorectal cancer for our subjects needed to be clarified in our future study.

Our results support that GSTT1 and GSTP1 might have a role in colorectal cancer susceptibility. The significant risk of the GSTT1 null genotype for colorectal cancer in our study might be due to the higher prevalence of GSTT1 null (49%) than in Caucasians (15-27%)[11]. Although the frequency of the GSTP1 G allele in our controls (17%) was lower than that in Caucasians (23-38%)[42], the large sample size enabled us to find a moderate relationship between the GSTP1 with G allele and an increased risk of colorectal cancer of men.

Consistent with other studies[37,43], this study also shows that risk factors for colorectal cancer is different between men and women in Taiwan. The GSTT1 null and GSTP1 with G allele genotypes were associated with increased risk of colorectal cancer, particularly in younger men and rectal cancer. The 2-fold increased risk of the GSTT1 null genotype relative to the GSTT1 present genotype for colorectal cancer in younger men is in line with other studies[15,19,44]. Studies in human suggest that the detoxification potential of the GST enzymes decreases with age[45]. It is possible that individuals with the null genotype develop tumors at a younger age than individuals that do express this enzyme. This study showed a slightly stronger genetic effect for the rectum over the colon. This was consistent with findings from previous studies[17,18]. The risks associated with diet tend to be the strongest in the distal colon for men[46]. Carcinogenesis within the distal colon has been associated with bulky-adduct-forming (BAF) agents[47]. The GST polymorphisms of reduced detoxification genotype might thus more likely predispose the rectum rather than the colon to cancer.

In studies on the combined effects of GST polymorphisms and vegetable/fruit consumption on colorectal lesions, three studies indicated that the high isothiocyanates content in cruciferous vegetables enhances the cancer preventive effect for humans with the GSTM1 or T1 null genotypes[27,28,30]. Potentially slower excretion of isothiocyanates induces GST. Other studies have reported that people with lower levels of enzyme activity (i.e., those with GSTM1 null genotype) obtain less protection from consuming cruciferous vegetables[48,49]. Our data showed that the greatest protective effect from higher vegetable/fruit consumption was observed for men with GSTT1 present or GSTP1 A/A genotypes, but for women with GSTT1 null or GSTP1 with G allele genotypes. In addition, Lampe et al[50] reported that brassica vegetables increased GSTA and GST activity for the GSTM1 null individuals in a randomized clinical tria. It is warranted to evaluate the gene-gene interactions of the polymorphic GST genes and their interactions with vegetables in further studies.

Because cruciferous vegetables not only induce phase I activating enzyme (e.g., cytochrome P4501A2 (CYP1A2)) and phase II inactivating enzyme (e.g., GST) expression and isothiocyanates themselves are a GST substrate[51], the delicate balance between phase I, phase II enzymes and their regulators is undoubtedly an important determinant for cancer risk. Although cigarette smoking seems not to interact with GST genes to affect the colorectal cancer risk[17,20,21,52], smoking can modify the association between GSTM1, cruciferous vegetables and colon cancer[30]. Because metabolizing enzymes can detoxify carcinogens in cigarette smoke, cigarette smoking might play a role in the balance of these enzymes and their regulators. Smoking might modify this effect by reducing the benefit for approximately 30% for the study subjects. It has been proven that among frequent consumers of cruciferous vegetables, smokers with the GSTM1 null genotype have CYP1A2 activity 2-fold over non-smokers with the GSTM1 present genotype[49]. Subjects with elevated CYP1A2 activity might be predisposed to colorectal cancer by activating heterocyclic amines and other procarcinogens[53].

Because GSTT1 and GSTP1 are expressed at higher level in colorectal tissue and were associated with colorectal cancer risk in men, we postulate that people with the genotype for higher detoxified enzyme activity and higher vegetable/fruit consumption exhibit multiplicative synergistic beneficial effect for reduced colorectal cancer risk. This protective effect is extended for non-smokers without enzyme activation or carcinogens exposure. On the other hand, if the detoxifying enzymes were not related to colorectal cancer risk, higher vegetable/fruit consumption could exert their beneficial effect without being excreted by metabolizing enzymes.

This study was limited by obtaining dietary information retrospectively after diagnosis. We cannot exclude the effect of early preclinical disease on the dietary habits in these colorectal cancer cases. This effect might be negligible because the difference in eating habit changes in the previous 10 years among cases and controls was not significant (P = 0.12). In addition, the similar interview settings provided reassurance against potential information bias. Other limitations arise from the questionnaire, which included only the diet frequency for major food groups. We could not assess the impact of potential carcinogens derived from processed food or the effects of specific macronutrient or micronutrient.

The strengths of our study are the inclusion of newly diagnosed and histologically confirmed adenocarcinoma colorectal cancer cases and using controls that received colonoscopies. The possibility of misclassification is minimal. This large sample size allowed stratified data analysis. The observed environmental effects in the study population agreed with other published studies[54] supporting the validity of our results.

Our study results suggest that the GSTT1 null genotype and the GSTP1 with G allele are potential risk alleles for colorectal cancer for the Chinese male population, but of beneficial effect for women with higher vegetable/fruit intake. The beneficial effect of vegetable/fruit on colorectal cancer is enhanced with GSTT1 present and GSTP1 A/A genotypes for both men and women, in particular for non-smokers. Studies with specific vegetable types, related metabolic enzymes and dietary regulators in different age groups and tumor sites would help to clarify the association.

Footnotes

Supported by National Science Council No. 89-2314-B-002-373, 90-2320-B-002-123 and 91-2320-B-002-121; National Health Research Institute No. 85-HR-516, 86-HR-516, and 87-HR-516

Edited by Li WZ Language Editor Elsevier HK

References

  • 1.Mannervik B, Awasthi YC, Board PG, Hayes JD, Di Ilio C, Ketterer B, Listowsky I, Morgenstern R, Muramatsu M, Pearson WR. Nomenclature for human glutathione transferases. Biochem J. 1992;282(Pt 1):305–306. doi: 10.1042/bj2820305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Ketterer B. Protective role of glutathione and glutathione transferases in mutagenesis and carcinogenesis. Mutat Res. 1988;202:343–361. doi: 10.1016/0027-5107(88)90197-2. [DOI] [PubMed] [Google Scholar]
  • 3.Prochaska HJ, Santamaria AB, Talalay P. Rapid detection of inducers of enzymes that protect against carcinogens. Proc Natl Acad Sci USA. 1992;89:2394–2398. doi: 10.1073/pnas.89.6.2394. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Zhang Y, Kolm RH, Mannervik B, Talalay P. Reversible conjugation of isothiocyanates with glutathione catalyzed by human glutathione transferases. Biochem Biophys Res Commun. 1995;206:748–755. doi: 10.1006/bbrc.1995.1106. [DOI] [PubMed] [Google Scholar]
  • 5.Kolm RH, Danielson UH, Zhang Y, Talalay P, Mannervik B. Isothiocyanates as substrates for human glutathione transferases: structure-activity studies. Biochem J. 1995;311(Pt 2):453–459. doi: 10.1042/bj3110453. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Seidegård J, Vorachek WR, Pero RW, Pearson WR. Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion. Proc Natl Acad Sci USA. 1988;85:7293–7297. doi: 10.1073/pnas.85.19.7293. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Pemble S, Schroeder KR, Spencer SR, Meyer DJ, Hallier E, Bolt HM, Ketterer B, Taylor JB. Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem J. 1994;300(Pt 1):271–276. doi: 10.1042/bj3000271. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Ali-Osman F, Akande O, Antoun G, Mao JX, Buolamwini J. Molecular cloning, characterization, and expression in Escherichia coli of full-length cDNAs of three human glutathione S-transferase Pi gene variants. Evidence for differential catalytic activity of the encoded proteins. J Biol Chem. 1997;272:10004–10012. doi: 10.1074/jbc.272.15.10004. [DOI] [PubMed] [Google Scholar]
  • 9.Norppa H. Genetic polymorphisms and chromosome damage. Int J Hyg Environ Health. 2001;204:31–38. doi: 10.1078/1438-4639-00069. [DOI] [PubMed] [Google Scholar]
  • 10.Gilliland FD, Harms HJ, Crowell RE, Li YF, Willink R, Belinsky SA. Glutathione S-transferase P1 and NADPH quinone oxidoreductase polymorphisms are associated with aberrant promoter methylation of P16(INK4a) and O(6)-methylguanine-DNA methyltransferase in sputum. Cancer Res. 2002;62:2248–2252. [PubMed] [Google Scholar]
  • 11.Cotton SC, Sharp L, Little J, Brockton N. Glutathione S-transferase polymorphisms and colorectal cancer: a HuGE review. Am J Epidemiol. 2000;151:7–32. doi: 10.1093/oxfordjournals.aje.a010124. [DOI] [PubMed] [Google Scholar]
  • 12.Seow A, Yuan JM, Sun CL, Van Den Berg D, Lee HP, Yu MC. Dietary isothiocyanates, glutathione S-transferase polymorphisms and colorectal cancer risk in the Singapore Chinese Health Study. Carcinogenesis. 2002;23:2055–2061. doi: 10.1093/carcin/23.12.2055. [DOI] [PubMed] [Google Scholar]
  • 13.Ye Z, Parry JM. Genetic polymorphisms in the cytochrome P450 1A1, glutathione S-transferase M1 and T1, and susceptibility to colon cancer. Teratog Carcinog Mutagen. 2002;22:385–392. doi: 10.1002/tcm.10035. [DOI] [PubMed] [Google Scholar]
  • 14.Tiemersma EW, Kampman E, Bueno de Mesquita HB, Bunschoten A, van Schothorst EM, Kok FJ, Kromhout D. Meat consumption, cigarette smoking, and genetic susceptibility in the etiology of colorectal cancer: results from a Dutch prospective study. Cancer Causes Control. 2002;13:383–393. doi: 10.1023/a:1015236701054. [DOI] [PubMed] [Google Scholar]
  • 15.Sgambato A, Campisi B, Zupa A, Bochicchio A, Romano G, Tartarone A, Galasso R, Traficante A, Cittadini A. Glutathione S-transferase (GST) polymorphisms as risk factors for cancer in a highly homogeneous population from southern Italy. Anticancer Res. 2002;22:3647–3652. [PubMed] [Google Scholar]
  • 16.Zhong S, Wyllie AH, Barnes D, Wolf CR, Spurr NK. Relationship between the GSTM1 genetic polymorphism and susceptibility to bladder, breast and colon cancer. Carcinogenesis. 1993;14:1821–1824. doi: 10.1093/carcin/14.9.1821. [DOI] [PubMed] [Google Scholar]
  • 17.Katoh T, Nagata N, Kuroda Y, Itoh H, Kawahara A, Kuroki N, Ookuma R, Bell DA. Glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) genetic polymorphism and susceptibility to gastric and colorectal adenocarcinoma. Carcinogenesis. 1996;17:1855–1859. doi: 10.1093/carcin/17.9.1855. [DOI] [PubMed] [Google Scholar]
  • 18.Deakin M, Elder J, Hendrickse C, Peckham D, Baldwin D, Pantin C, Wild N, Leopard P, Bell DA, Jones P, et al. Glutathione S-transferase GSTT1 genotypes and susceptibility to cancer: studies of interactions with GSTM1 in lung, oral, gastric and colorectal cancers. Carcinogenesis. 1996;17:881–884. doi: 10.1093/carcin/17.4.881. [DOI] [PubMed] [Google Scholar]
  • 19.Welfare M, Monesola Adeokun A, Bassendine MF, Daly AK. Polymorphisms in GSTP1, GSTM1, and GSTT1 and susceptibility to colorectal cancer. Cancer Epidemiol Biomarkers Prev. 1999;8:289–292. [PubMed] [Google Scholar]
  • 20.Yoshioka M, Katoh T, Nakano M, Takasawa S, Nagata N, Itoh H. Glutathione S-transferase (GST) M1, T1, P1, N-acetyltransferase (NAT) 1 and 2 genetic polymorphisms and susceptibility to colorectal cancer. J UOEH. 1999;21:133–147. doi: 10.7888/juoeh.21.133. [DOI] [PubMed] [Google Scholar]
  • 21.Katoh T, Kaneko S, Takasawa S, Nagata N, Inatomi H, Ikemura K, Itoh H, Matsumoto T, Kawamoto T, Bell DA. Human glutathione S-transferase P1 polymorphism and susceptibility to smoking related epithelial cancer; oral, lung, gastric, colorectal and urothelial cancer. Pharmacogenetics. 1999;9:165–169. [PubMed] [Google Scholar]
  • 22.Caporaso N, Landi MT, Vineis P. Relevance of metabolic polymorphisms to human carcinogenesis: evaluation of epidemiologic evidence. Pharmacogenetics. 1991;1:4–19. doi: 10.1097/00008571-199110000-00003. [DOI] [PubMed] [Google Scholar]
  • 23.Doll R, Peto R. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst. 1981;66:1191–1308. [PubMed] [Google Scholar]
  • 24.Thomas HJ. Familial colorectal cancer. BMJ. 1993;307:277–278. doi: 10.1136/bmj.307.6899.277. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Armstrong B, Doll R. Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices. Int J Cancer. 1975;15:617–631. doi: 10.1002/ijc.2910150411. [DOI] [PubMed] [Google Scholar]
  • 26.Kiyohara C. Genetic polymorphism of enzymes involved in xenobiotic metabolism and the risk of colorectal cancer. J Epidemiol. 2000;10:349–360. doi: 10.2188/jea.10.349. [DOI] [PubMed] [Google Scholar]
  • 27.Lin HJ, Probst-Hensch NM, Louie AD, Kau IH, Witte JS, Ingles SA, Frankl HD, Lee ER, Haile RW. Glutathione transferase null genotype, broccoli, and lower prevalence of colorectal adenomas. Cancer Epidemiol Biomarkers Prev. 1998;7:647–652. [PubMed] [Google Scholar]
  • 28.Kiss I, Sándor J, Ember I. Allelic polymorphism of GSTM1 and NAT2 genes modifies dietary-induced DNA damage in colorectal mucosa. Eur J Cancer Prev. 2000;9:429–432. doi: 10.1097/00008469-200012000-00009. [DOI] [PubMed] [Google Scholar]
  • 29.Slattery ML, Potter JD, Ma KN, Caan BJ, Leppert M, Samowitz W. Western diet, family history of colorectal cancer, NAT2, GSTM-1 and risk of colon cancer. Cancer Causes Control. 2000;11:1–8. doi: 10.1023/a:1008913619957. [DOI] [PubMed] [Google Scholar]
  • 30.Slattery ML, Kampman E, Samowitz W, Caan BJ, Potter JD. Interplay between dietary inducers of GST and the GSTM-1 genotype in colon cancer. Int J Cancer. 2000;87:728–733. [PubMed] [Google Scholar]
  • 31.Lee E, Huang Y, Zhao B, Seow-Choen F, Balakrishnan A, Chan SH. Genetic polymorphism of conjugating enzymes and cancer risk: GSTM1, GSTT1, NAT1 and NAT2. J Toxicol Sci. 1998;23 Suppl 2:140–142. [PubMed] [Google Scholar]
  • 32.Guo JY, Wan DS, Zeng RP, Zhang Q. The polymorphism of GSTM1, mutagen sensitivity in colon cancer and healthy control. Mutat Res. 1996;372:17–22. doi: 10.1016/S0027-5107(96)00093-0. [DOI] [PubMed] [Google Scholar]
  • 33.Harris MJ, Coggan M, Langton L, Wilson SR, Board PG. Polymorphism of the Pi class glutathione S-transferase in normal populations and cancer patients. Pharmacogenetics. 1998;8:27–31. doi: 10.1097/00008571-199802000-00004. [DOI] [PubMed] [Google Scholar]
  • 34.Yeh CC, Hsieh LL, Tang R, Chang-Chieh CR, Sung FC. Risk factors for colorectal cancer in Taiwan: a hospital-based case-control study. J Formos Med Assoc. 2003;102:305–312. [PubMed] [Google Scholar]
  • 35.Huang CY, Huang KL, Cheng TJ, Wang JD, Hsieh LL. The GST T1 and CYP2E1 genotypes are possible factors causing vinyl chloride induced abnormal liver function. Arch Toxicol. 1997;71:482–488. doi: 10.1007/s002040050416. [DOI] [PubMed] [Google Scholar]
  • 36.Harries LW, Stubbins MJ, Forman D, Howard GC, Wolf CR. Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer. Carcinogenesis. 1997;18:641–644. doi: 10.1093/carcin/18.4.641. [DOI] [PubMed] [Google Scholar]
  • 37.Tang R, Wang JY, Lo SK, Hsieh LL. Physical activity, water intake and risk of colorectal cancer in Taiwan: a hospital-based case-control study. Int J Cancer. 1999;82:484–489. doi: 10.1002/(sici)1097-0215(19990812)82:4<484::aid-ijc3>3.0.co;2-a. [DOI] [PubMed] [Google Scholar]
  • 38.Nijhoff WA, Grubben MJ, Nagengast FM, Jansen JB, Verhagen H, van Poppel G, Peters WH. Effects of consumption of Brussels sprouts on intestinal and lymphocytic glutathione S-transferases in humans. Carcinogenesis. 1995;16:2125–2128. doi: 10.1093/carcin/16.9.2125. [DOI] [PubMed] [Google Scholar]
  • 39.de Bruin WC, Wagenmans MJ, Board PG, Peters WH. Expression of glutathione S-transferase theta class isoenzymes in human colorectal and gastric cancers. Carcinogenesis. 1999;20:1453–1457. doi: 10.1093/carcin/20.8.1453. [DOI] [PubMed] [Google Scholar]
  • 40.Lin D, Meyer DJ, Ketterer B, Lang NP, Kadlubar FF. Effects of human and rat glutathione S-transferases on the covalent DNA binding of the N-acetoxy derivatives of heterocyclic amine carcinogens in vitro: a possible mechanism of organ specificity in their carcinogenesis. Cancer Res. 1994;54:4920–4926. [PubMed] [Google Scholar]
  • 41.Coles BF, Morel F, Rauch C, Huber WW, Yang M, Teitel CH, Green B, Lang NP, Kadlubar FF. Effect of polymorphism in the human glutathione S-transferase A1 promoter on hepatic GSTA1 and GSTA2 expression. Pharmacogenetics. 2001;11:663–669. doi: 10.1097/00008571-200111000-00004. [DOI] [PubMed] [Google Scholar]
  • 42.Coughlin SS, Hall IJ. Glutathione S-transferase polymorphisms and risk of ovarian cancer: a HuGE review. Genet Med. 2002;4:250–257. doi: 10.1097/00125817-200207000-00003. [DOI] [PubMed] [Google Scholar]
  • 43.Iacopetta B. Are there two sides to colorectal cancer? Int J Cancer. 2002;101:403–408. doi: 10.1002/ijc.10635. [DOI] [PubMed] [Google Scholar]
  • 44.Chenevix-Trench G, Young J, Coggan M, Board P. Glutathione S-transferase M1 and T1 polymorphisms: susceptibility to colon cancer and age of onset. Carcinogenesis. 1995;16:1655–1657. doi: 10.1093/carcin/16.7.1655. [DOI] [PubMed] [Google Scholar]
  • 45.van Lieshout EM, Peters WH. Age and gender dependent levels of glutathione and glutathione S-transferases in human lymphocytes. Carcinogenesis. 1998;19:1873–1875. doi: 10.1093/carcin/19.10.1873. [DOI] [PubMed] [Google Scholar]
  • 46.McMichael AJ, Potter JD. Diet and colon cancer: integration of the descriptive, analytic, and metabolic epidemiology. Natl Cancer Inst Monogr. 1985;69:223–228. [PubMed] [Google Scholar]
  • 47.Breivik J, Gaudernack G. Carcinogenesis and natural selection: a new perspective to the genetics and epigenetics of colorectal cancer. Adv Cancer Res. 1999;76:187–212. doi: 10.1016/s0065-230x(08)60777-0. [DOI] [PubMed] [Google Scholar]
  • 48.Whalen R, Boyer TD. Human glutathione S-transferases. Semin Liver Dis. 1998;18:345–358. doi: 10.1055/s-2007-1007169. [DOI] [PubMed] [Google Scholar]
  • 49.Probst-Hensch NM, Tannenbaum SR, Chan KK, Coetzee GA, Ross RK, Yu MC. Absence of the glutathione S-transferase M1 gene increases cytochrome P4501A2 activity among frequent consumers of cruciferous vegetables in a Caucasian population. Cancer Epidemiol Biomarkers Prev. 1998;7:635–638. [PubMed] [Google Scholar]
  • 50.Lampe JW, Chen C, Li S, Prunty J, Grate MT, Meehan DE, Barale KV, Dightman DA, Feng Z, Potter JD. Modulation of human glutathione S-transferases by botanically defined vegetable diets. Cancer Epidemiol Biomarkers Prev. 2000;9:787–793. [PubMed] [Google Scholar]
  • 51.Lampe JW, Peterson S. Brassica, biotransformation and cancer risk: genetic polymorphisms alter the preventive effects of cruciferous vegetables. J Nutr. 2002;132:2991–2994. doi: 10.1093/jn/131.10.2991. [DOI] [PubMed] [Google Scholar]
  • 52.Slattery ML, Potter JD, Samowitz W, Bigler J, Caan B, Leppert M. NAT2, GSTM-1, cigarette smoking, and risk of colon cancer. Cancer Epidemiol Biomarkers Prev. 1998;7:1079–1084. [PubMed] [Google Scholar]
  • 53.Lang NP, Butler MA, Massengill J, Lawson M, Stotts RC, Hauer-Jensen M, Kadlubar FF. Rapid metabolic phenotypes for acetyltransferase and cytochrome P4501A2 and putative exposure to food-borne heterocyclic amines increase the risk for colorectal cancer or polyps. Cancer Epidemiol Biomarkers Prev. 1994;3:675–682. [PubMed] [Google Scholar]
  • 54.Potter JD, Slattery ML, Bostick RM, Gapstur SM. Colon cancer: a review of the epidemiology. Epidemiol Rev. 1993;15:499–545. doi: 10.1093/oxfordjournals.epirev.a036132. [DOI] [PubMed] [Google Scholar]

Articles from World Journal of Gastroenterology : WJG are provided here courtesy of Baishideng Publishing Group Inc

RESOURCES